Elite Pharmaceuticals Inc
OTC:ELTP

Watchlist Manager
Elite Pharmaceuticals Inc Logo
Elite Pharmaceuticals Inc
OTC:ELTP
Watchlist
Price: 0.49 USD 1.03% Market Closed
Market Cap: 526.5m USD

Operating Margin
Elite Pharmaceuticals Inc

35.5%
Current
18%
Average
6%
Industry

Operating Margin represents how efficiently a company is able to generate profit through its core operations.

Higher ratios are generally better, illustrating the company is efficient in its operations and is good at turning sales into profits.

Operating Margin
35.5%
=
Operating Profit
37.4m
/
Revenue
105.5m

Operating Margin Across Competitors

No Stocks Found

Elite Pharmaceuticals Inc
Glance View

Market Cap
523.5m USD
Industry
Pharmaceuticals

Elite Pharmaceuticals, Inc. engages in the development and manufacture of pharmacological abuse-deterrent opioid products. The company is headquartered in Northvale, New Jersey and currently employs 43 full-time employees. The company went IPO on 2014-02-20. The firm is principally engaged in the development and manufacture of oral, controlled-release products. The firm develops and manufactures generic products, products using controlled-release drug technology, products utilizing abuse deterrent technologies, and it develops and markets (either on its own or by license to other companies) generic controlled-release and abuse deterrent pharmaceutical products. Its segments include Abbreviated New Drug Applications (ANDA) for generic products and New Drug Applications (NDA) for branded products. Elite owns, licenses and contract manufactures products, including Phentermine HCl 37.5mg tablets , Phendimetrazine Tartrate 35mg tablets, Naltrexone HCl 50mg tablets, Isradipine 2.5mg and 5mg capsules, Oxycodone HCl Immediate Release 5mg, 10mg, 15mg, 20mg and 30mg tablets, Trimipramine Maleate Immediate Release 25mg, 50mg and 100mg capsules, among others.

ELTP Intrinsic Value
0.53 USD
Undervaluation 7%
Intrinsic Value
Price
What is Operating Margin?

Operating Margin represents how efficiently a company is able to generate profit through its core operations.

Higher ratios are generally better, illustrating the company is efficient in its operations and is good at turning sales into profits.

Operating Margin
35.5%
=
Operating Profit
37.4m
/
Revenue
105.5m
What is the Operating Margin of Elite Pharmaceuticals Inc?

Based on Elite Pharmaceuticals Inc's most recent financial statements, the company has Operating Margin of 35.5%.

Back to Top